Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Stimulation Clicker is another absolute banger from creator Neal Agarwal, whose weird little browser games are always a delight. In Stimulation Clicker you click a button to gain stimulation ...

Stimulation Clicker satirizes how it can feel to gobble up the web by filling up the screen with internet videos, stock charts and Duolingo questions. There’s email to answer, too. By Kieran ...

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the ...

Nevro’s comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic ...

In a report released on February 7, Nathan Treybeck from Wells Fargo maintained a Hold rating on Nevro Corp (NVRO – Research Report), with a price target of $5.85. The company’s shares closed ...

Nevro’s comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...